Greatmark Investment Partners’s Eli Lilly LLY Stock Holding History

Greatmark Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.21M	Sell	2,673 -16	-0.6%	-$16.3K	0.35%	55
2026 Q1	$2.47M	Sell	2,689 -9	-0.3%	-$9.12K	0.29%	57
2025 Q4	$2.9M	Buy	2,698 +200	+8%	+$191K	0.34%	51
2025 Q3	$1.91M	Sell	2,498 -47	-2%	-$35K	0.23%	66
2025 Q2	$1.98M	Hold	2,545	–	–	0.25%	64
2025 Q1	$2.1M	Buy	2,545 +200	+9%	+$166K	0.29%	55
2024 Q4	$1.81M	Sell	2,345 -27	-1%	-$22.4K	0.25%	58
2024 Q3	$2.1M	Hold	2,372	–	–	0.28%	57
2024 Q2	$2.15M	Sell	2,372 -15	-0.6%	-$12K	0.31%	53
2024 Q1	$1.86M	Buy	2,387 +64	+3%	+$45.5K	0.26%	60
2023 Q4	$1.35M	Buy	2,323 +1	+0%	+$584	0.21%	62
2023 Q3	$1.25M	Sell	2,322 -5	-0.2%	-$2.58K	0.22%	61
2023 Q2	$1.09M	Sell	2,327 -180	-7%	-$75.5K	0.18%	68
2023 Q1	$861K	Hold	2,507	–	–	0.15%	73
2022 Q4	$917K	Hold	2,507	–	–	0.17%	65
2022 Q3	$811K	Hold	2,507	–	–	0.16%	70
2022 Q2	$813K	Hold	2,507	–	–	0.16%	71
2022 Q1	$718K	Hold	2,507	–	–	0.12%	80
2021 Q4	$692K	Hold	2,507	–	–	0.12%	83
2021 Q3	$579K	Hold	2,507	–	–	0.11%	88
2021 Q2	$575K	Hold	2,507	–	–	0.1%	86
2021 Q1	$468K	Hold	2,507	–	–	0.09%	98
2020 Q4	$423K	Sell	2,507 -25	-1%	-$3.73K	0.09%	96
2020 Q3	$375K	Sell	2,532 -75	-3%	-$11.6K	0.09%	97
2020 Q2	$428K	Sell	2,607 -200	-7%	-$30.7K	0.11%	87
2020 Q1	$389K	Sell	2,807 -100	-3%	-$13.7K	0.13%	78
2019 Q4	$382K	Hold	2,907	–	–	0.09%	93
2019 Q3	$325K	Hold	2,907	–	–	0.09%	96
2019 Q2	$322K	Hold	2,907	–	–	0.1%	94
2019 Q1	$377K	Hold	2,907	–	–	0.12%	88
2018 Q4	$336K	Hold	2,907	–	–	0.12%	86
2018 Q3	$312K	Hold	2,907	–	–	0.1%	96
2018 Q2	$248K	Buy	2,907 +200	+7%	+$16.4K	0.09%	99
2018 Q1	$209K	Sell	2,707 -1,000	-27%	-$80.5K	0.08%	109
2017 Q4	$313K	Hold	3,707	–	–	0.11%	90
2017 Q3	$317K	Hold	3,707	–	–	0.12%	86
2017 Q2	$305K	Sell	3,707 -225	-6%	-$18.4K	0.12%	81
2017 Q1	$331K	Hold	3,932	–	–	0.14%	77
2016 Q4	$289K	Buy	3,932 +1,220	+45%	+$90.9K	0.12%	78
2016 Q3	$218K	Sell	2,712 -2,529	-48%	-$202K	0.09%	86
2016 Q2	$413K	Hold	5,241	–	–	0.18%	68
2016 Q1	$377K	Hold	5,241	–	–	0.17%	65
2015 Q4	$442K	Hold	5,241	–	–	0.19%	61
2015 Q3	$439K	Hold	5,241	–	–	0.2%	59
2015 Q2	$438K	Hold	5,241	–	–	0.19%	61
2015 Q1	$381K	Hold	5,241	–	–	0.16%	69
2014 Q4	$362K	Hold	5,241	–	–	0.15%	71
2014 Q3	$340K	Buy	5,241 +500	+11%	+$31.7K	0.16%	71
2014 Q2	$295K	Hold	4,741	–	–	0.12%	72
2014 Q1	$279K	Hold	4,741	–	–	0.12%	71
2013 Q4	$242K	Sell	4,741 -1,000	-17%	-$50.1K	0.11%	76
2013 Q3	$289K	Hold	5,741	–	–	0.15%	68
2013 Q2	$282K	Buy	+5,741	New	+$312K	0.18%	68

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Greatmark Investment Partners's LLY Position: Q2 2026 in Review

Greatmark Investment Partners reduced its Eli Lilly (LLY) stake by 0.6% in Q2 2026, selling an estimated $16.3K and leaving 2,673 shares worth $3.21M. The position accounts for 0.35% of the portfolio, ranked #55.

Greatmark Investment Partners first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Greatmark Investment Partners held 2,673 shares of Eli Lilly worth $3.21M as of Q2 2026.
Greatmark Investment Partners sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
Eli Lilly made up 0.35% of Greatmark Investment Partners's portfolio in Q2 2026, its #55 holding.
Greatmark Investment Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.